[1]CurrentPatentAssignee:ASTELLASPHARMAINC.-EP2154130,2010,A1Locationinpatent:Page/Pagecolumn32-33
[1]Patent:WO2013/190355,2013,A1.Locationinpatent:Page/Pagecolumn14;15
[2]Patent:WO2016/98054,2016,A1.Locationinpatent:Page/Pagecolumn46;47
[1]CurrentPatentAssignee:ED.GEISTLICHSOHNEAGFURCHEMISCHEINDUSTRIE-WO2013/190355,2013,A1Locationinpatent:Page/Pagecolumn14;15
[2]CurrentPatentAssignee:ED.GEISTLICHSOHNEAGFURCHEMISCHEINDUSTRIE-WO2016/98054,2016,A1Locationinpatent:Page/Pagecolumn46;47
[1]CurrentPatentAssignee:ED.GEISTLICHSOHNEAGFURCHEMISCHEINDUSTRIE-WO2016/98054,2016,A1Locationinpatent:Page/Pagecolumn39
[1]CurrentPatentAssignee:ED.GEISTLICHSOHNEAGFURCHEMISCHEINDUSTRIE-WO2016/98054,2016,A1Locationinpatent:Page/Pagecolumn27;32;33
[2]CurrentPatentAssignee:ED.GEISTLICHSOHNEAGFURCHEMISCHEINDUSTRIE-WO2017/175177,2017,A1Locationinpatent:Paragraph6
Title: Synthesis and antimalarial activity of thioetherhydroxyethylsulfonamides, potential aspartyl protease inhibitors, Part 3.
Journal: European journal of medicinal chemistry 20111101
Title: N-{(2S)-3-Hy-droxy-4-[(5-methyl-1,3,4-thia-diazol-2-yl)sulfan-yl]-1-phenyl-2-but-yl}-4-methyl-benzene-sulfonamide.
Journal: Acta crystallographica. Section E, Structure reports online 20110901
Title: Antiviral activity of UIC-PI, a novel inhibitor of the human immunodeficiency virus type 1 protease.
Journal: Antiviral research 20020401